Anaplastic large cell lymphoma and breast implants: Results from a structured expert consultation process

Plastic and Reconstructive Surgery

Volumn 128, Issue 3, 2011, Pages 629-639

  Kim, Benjamin ^a,b   Roth, Carol ^a,b   Young, V Leroy ^a,b   Chung, Kevin C ^a,b   Van Busum, Kristin ^a,b   Schnyer, Christopher ^a,b   Mattke, Soeren ^a,b  

^a RAND Corporation ^*

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PROTEIN TYROSINE KINASE; TUMOR MARKER;

BREAST ENDOPROSTHESIS; BREAST TUMOR; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; PATHOLOGY; PATIENT REFERRAL; POSTOPERATIVE COMPLICATION; PROGNOSIS; REOPERATION; REVIEW; RISK FACTOR; SEROMA; STATISTICS;

BREAST IMPLANTS; BREAST NEOPLASMS; CAUSALITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; REFERRAL AND CONSULTATION; REOPERATION; RISK FACTORS; SEROMA; TUMOR MARKERS, BIOLOGICAL;

EID: 80052456656     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31821f9f23     Document Type: Article

References (53)

1. Duvic M, Moore D, Menter A, Vonderheid EC. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol. 1995;32:939-942.
2. U.S. Food and Drug Administration Center for Devices and Radiological Health. FDA medical device safety communication: Reports of anaplastic large cell lymphoma (ALCL) in women with breast implants. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm240000.htm. Accessed January 26, 2011.
3. Brody G, Deapen D, Gill P, et al. T-cell non Hodgkin's anaplastic lymphoma associated with one style of breast implants. Paper presented at: 89th Annual Meeting of the American Association of Plastic Surgeons; March 20-23, 2010; San Antonio, Texas.
4. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-2795.
5. Cohen PL, Brooks JJ. Lymphomas of the breast: A clinicopathologic and immunohistochemical study of primary and secondary cases. Cancer 1991;67:1359-1369.
6. Brogi E, Harris NL. Lymphomas of the breast: Pathology and clinical behavior. Semin Oncol. 1999;26:357-364.
7. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1972;29:1705-1712.
8. Kim B, Roth C, Chung KC, et al. Anaplastic large cell lymphoma and breast implants: A systematic review. Plast Reconstr Surg. 2011;127:2141-2150.
9. Fitch K, Bernstein SJ, Aguilar MS, Burnand B, LaCalle JR. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, Calif: RAND Corp; 2001.
10. Shekelle PG, Kahan JP, Bernstein SJ, Leape LL, Kamberg CJ, Park RE. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med. 1998;338:1888-1895.
11. Hodgson DC, Brierley JD, Cernat G, et al. The consistency of panelists' appropriateness ratings: Do experts produce clinically logical scores for rectal cancer treatment? Health Policy 2005;71:57-65.
12. Hemingway H, Crook AM, Feder G, et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med. 2001;344:645-654.
13. Santori G, Fontana I, Valente R, Ghirelli R, Valente U. Application of the RAND/UCLA Appropriateness Method to evaluate an information system for kidney/pancreas transplantation in adult recipients. Transplant Proc. 2008;40:2021-2023.
14. Santori G, Andorno E, Valente R, Ghirelli R, Valente U. Application of the RAND/UCLA appropriateness method to evaluate an informative system for liver transplantation in adult and pediatric recipients. Transplant Proc. 2007;39:1927-1929.
15. Santori G, Valente R, Cambiaso F, Ghirelli R, Gianelli Castiglione A, Valente U. Preliminary results of an expert-opinion elicitation process to prioritize an informative system funded by Italian Ministry of Health for cadaveric donor management, organ allocation, and transplantation activity. Transplant Proc. 2004;36:433-434.
16. Shekelle PG, Chassin MR, Park RE. Assessing the predictive validity of the RAND/UCLA appropriateness method criteria for performing carotid endarterectomy. Int J Technol Assess Health Care 1998;14:707-727.
17. Gale RP, Park RE, Dubois R, et al. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer. Clin Transplant. 2000;14:32-41.
18. Dubois RW, Swetter SM, Atkins M, et al. Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. Arch Dermatol. 2001;137:1217-1224.
19. Poston GJ, Adam R, Alberts S, et al. OncoSurge: A strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005;23:7125-7134.
20. Gale RP, Park RE, Dubois RW, et al. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma. Leuk Lymphoma 1999;33:511-519.
21. Gale RP, Park RE, Dubois RW, et al. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase. Leuk Res. 1999;23:817-826.
22. Gale RP, Park RE, Dubois RW, et al. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission. Leuk Res. 1999;23:709-718.
23. Gale RP, Park RE, Dubois R, et al. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. Leuk Lymphoma 1998;32:139-149.
24. Lechner M, Lade S, Brody G, Epstein A. Breast implantassociated T cell anaplastic large-cell lymphoma: Case report and establishment of a novel cell line (Tlbr-1). J Invest Med. 2010;58:84.
25. Hanson SE, Gutowski KA. Primary T-cell lymphoma associated with breast implant capsule. Plast Reconstr Surg. 2010; 126:39e-41e.
26. Li S, Lee AK. Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol. 2009;3:117-127.
27. Mora P, Melo AC, Amorim GLS, Scheliga AA. Primary T-cell anaplastic lymphoma associated to a breast implant: Case report. Haematologica 2009;94:658-659.
28. Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ. Anaplastic large cell lymphoma involving the breast: A clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med. 2009;133:1383-1390.
29. Gualco G, Chioato L, Harrington WJ Jr, Weiss LM, Bacchi CE. Primary and secondary T-cell lymphomas of the breast: Clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol. 2009;17:301-306.
30. Farkash EA, Ferry JA, Harris NL, et al. Rare lymphoid malignancies of the breast: A report of two cases illustrating potential diagnostic pitfalls. J Hematop. 2009;2:237-244.
31. Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: An unusual case presentation. Diagn Pathol. 2009;4:11.
32. Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 2009;50:831-833.
33. Wong AK, Lopategui J, Clancy S, Kulber D, Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: A case report and review of the literature. Am J Surg Pathol. 2008;32:1265-1268.
34. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: An indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008;21:455-463.
35. Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: A case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008;61:822-825.
36. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300: 2030-2035.
37. Olack B, Gupta R, Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg. 2007;59:56-57.
38. Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer: A case report. Virchows Arch. 2006;449:561-564.
39. Kraemer DM, Tony HP, Gattenlöhner S, Mü ller JG. Lymphoplasmacytic lymphoma in a patient with leaking silicone implant. Haematologica 2004;89:ELT01.
40. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: A case report and review of the literature. Arch Pathol Lab Med. 2003;127:e115-e118.
41. Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. Breast lymphoma associated with breast implants: Two casereports and a review of the literature. Leuk Lymphoma 2002; 43:115-119.
42. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100:554-555.
43. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: Report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996;88: 3124-3128.
44. Sendagorta E, Ledo A. Sézary syndrome in association with silicone breast implant. J Am Acad Dermatol. 1995;33:1060-1061.
45. Cook PD, Osborne BM, Connor RL, Strauss JF. Follicular lymphoma adjacent to foreign body granulomatous inflammation and fibrosis surrounding silicone breast prosthesis. Am J Surg Pathol. 1995;19:712-717.
46. Lipworth L, Tarone RE, Friis S, et al. Cancer among Scandinavian women with cosmetic breast implants: A pooled long-term follow-up study. Int J Cancer 2009;124:490-493.
47. Deapen DM, Hirsch EM, Brody GS. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg. 2007;119:1987-1992.
48. Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 2006;118:2854-2862.
49. Pukkala E, Boice JD Jr, Hovi SL, et al. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants 2002;12: 271-279.
50. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol. 2001;11: 248-256.
51. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: A review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009;123:790-793.
52. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-1392.
53. Google Search. Breast implant, anaplastic large cell lymphoma. Availableat:http://www.google.com/#sclient-psy& hl-en&tbs-nws: 1%2Cqdr%3Aw&q-breast-implant%2C-anaplastic-large-cell-lymphoma&aq- &aqi-&aql-&oq-&pbx-1&fp-b6d4941f59da55ab. Accessed February 1, 2011.